Cellular Basis for Therapeutic Choices in Heart Failure

Lionel H. Opie

doi:10.1161/01.cir.0000146803.14063.f7

October 25, 2004Circulation

Cellular Basis for Therapeutic Choices in Heart Failure

View at Publisher

Ask AI

Bookmark

Share

Key Points

To examine the cellular and molecular mechanisms underlying myocardial dysfunction in heart failure to provide a biological rationale for selecting therapeutic interventions.
Narrative review synthesizing findings on cardiomyocyte biology, neurohormonal activation, and pharmacological mechanisms in heart failure.
Identifies alterations in cardiomyocyte calcium handling, excitation-contraction coupling, and energetic pathways as fundamental targets for therapeutic intervention.
Highlights that selecting therapies based on specific cellular mechanisms can mitigate adverse cardiac remodeling and preserve contractile function.

PICO

P

Population

Heart Failure

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Review reveals cellular and molecular targets for medical management in heart failure patients, highlighting mechanisms guiding rational drug selection.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lionel H. Opie (2004) studied Heart Failure.

synapsesocial.com/papers/6a9a9f9ccebd556a1577ba53 https://doi.org/10.1161/01.cir.0000146803.14063.f7

View at Publisher

Ask AI

Bookmark

Share

Cellular Basis for Therapeutic Choices in Heart Failure

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Cellular Basis for Therapeutic Choices in Heart Failure

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading